OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phencyclidine-induced disruption of oscillatory activity in prefrontal cortex: Effects of antipsychotic drugs and receptor ligands
Laia Lladó-Pelfort, Eva Troyano-Rodriguez, Hanna E. van den Munkhof, et al.
European Neuropsychopharmacology (2015) Vol. 26, Iss. 3, pp. 614-625
Closed Access | Times Cited: 23

Showing 23 citing articles:

Neurotransmitters: The Critical Modulators Regulating Gut–Brain Axis
Rahul Mittal, Luca H. Debs, Amit Patel, et al.
Journal of Cellular Physiology (2016) Vol. 232, Iss. 9, pp. 2359-2372
Open Access | Times Cited: 508

Pathogenic Mis-splicing of CPEB4 in Schizophrenia
Ivana Ollà, Antonio F. Pardiñas, Alberto Parras, et al.
Biological Psychiatry (2023) Vol. 94, Iss. 4, pp. 341-351
Open Access | Times Cited: 13

The serotonin hallucinogen 5-MeO-DMT alters cortico-thalamic activity in freely moving mice: Regionally-selective involvement of 5-HT1A and 5-HT2A receptors
Maurizio S. Riga, Laia Lladó-Pelfort, Francesc Artigas, et al.
Neuropharmacology (2017) Vol. 142, pp. 219-230
Open Access | Times Cited: 48

In vivo electrophysiological recordings of the effects of antidepressant drugs
Paul J. Fitzgerald, Brendon O. Watson
Experimental Brain Research (2019) Vol. 237, Iss. 7, pp. 1593-1614
Open Access | Times Cited: 40

Defining the brain circuits involved in psychiatric disorders: IMI-NEWMEDS
Francesc Artigas, Esther Schenker, Pau Celada, et al.
Nature Reviews Drug Discovery (2016) Vol. 16, Iss. 1, pp. 1-2
Closed Access | Times Cited: 37

Clozapine counteracts a ketamine-induced depression of hippocampal-prefrontal neuroplasticity and alters signaling pathway phosphorylation
Marion Rame, Dorian Caudal, Esther Schenker, et al.
PLoS ONE (2017) Vol. 12, Iss. 5, pp. e0177036-e0177036
Open Access | Times Cited: 25

Temporally dissociable effects of ketamine on neuronal discharge and gamma oscillations in rat thalamo-cortical networks
Maria Amat-Foraster, Anders A. Jensen, Niels Plath, et al.
Neuropharmacology (2018) Vol. 137, pp. 13-23
Open Access | Times Cited: 25

Modulation of thalamo-cortical activity by the NMDA receptor antagonists ketamine and phencyclidine in the awake freely-moving rat
Maria Amat-Foraster, Pau Celada, Ulrike Richter, et al.
Neuropharmacology (2019) Vol. 158, pp. 107745-107745
Open Access | Times Cited: 24

Involvement of NMDA receptors containing the GluN2C subunit in the psychotomimetic and antidepressant-like effects of ketamine
Mireia Tarrés-Gatius, Lluís Miquel-Rio, Leticia Campa, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 21

Depression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: Antipodes of psychiatric disorders
Joanna M. Wierońska, Andrzej Pilc
Pharmacology & Therapeutics (2018) Vol. 193, pp. 75-82
Closed Access | Times Cited: 18

Effects of Hallucinogens on Neuronal Activity
Laia Lladó-Pelfort, Pau Celada, Maurizio S. Riga, et al.
Current topics in behavioral neurosciences (2017), pp. 75-105
Closed Access | Times Cited: 16

Sub-chronic vortioxetine (but not escitalopram) normalizes brain rhythm alterations and memory deficits induced by serotonin depletion in rats
Maurizio S. Riga, Connie Sánchez, Pau Celada, et al.
Neuropharmacology (2020) Vol. 178, pp. 108238-108238
Open Access | Times Cited: 12

Optogenetic inhibition of ventral hippocampal neurons alleviates associative motor learning dysfunction in a rodent model of schizophrenia
Zheng-li Fan, Bing Wu, Guangyan Wu, et al.
PLoS ONE (2019) Vol. 14, Iss. 12, pp. e0227200-e0227200
Open Access | Times Cited: 10

The antipsychotic drug brexpiprazole reverses phencyclidine-induced disruptions of thalamocortical networks
Hanna E. van den Munkhof, Jørn Arnt, Pau Celada, et al.
European Neuropsychopharmacology (2017) Vol. 27, Iss. 12, pp. 1248-1257
Open Access | Times Cited: 5

Dual 5-HT3 and 5-HT6 Receptor Antagonist FPPQ Normalizes Phencyclidine-Induced Disruption of Brain Oscillatory Activity in Rats
Anna Castañé, Montserrat Cano, Luis Ruíz-Ávila, et al.
The International Journal of Neuropsychopharmacology (2022) Vol. 25, Iss. 5, pp. 425-431
Open Access | Times Cited: 4

Effects of Ziprasidone or Haloperidol on Theory of Mind in Patients With Schizophrenia: A 16-week Pilot Trial
Jie Zhong, Yuan Jia, Zhu Hong, et al.
Journal of Psychiatric Practice (2024) Vol. 30, Iss. 1, pp. 32-42
Closed Access

Lu AF35700 reverses the phencyclidine-induced disruption of thalamo-cortical activity by blocking dopamine D1 and D2 receptors
Maurizio S. Riga, Veronica Paz, Michael Didriksen, et al.
European Journal of Pharmacology (2023) Vol. 953, pp. 175802-175802
Closed Access | Times Cited: 1

Pathogenic mis-splicing of CPEB4 in schizophrenia
Ivana Ollà, Antonio F. Pardiñas, Alberto Parras, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1

A Paradigm Shift from DSM-5 to Research Domain Criteria: Application to Translational CNS Drug Development
William Z. Potter, Bruce N. Cuthbert
Springer eBooks (2021), pp. 211-227
Closed Access | Times Cited: 1

Page 1

Scroll to top